Woodfield Clinical Consulting, LLC has a diverse range of clients, from “big” Pharma to small “start-ups”. It has also accomplished a number of varied tasks for them. For Bristol-Myers Squibb we were instrumental in the filing of the NDA for Pravigard® and the preparation for the FDA Cardio-Renal Advisory Committee. For some of the smaller companies it has been the filing of the IND and the design of the “First in Man Study” with the follow-up rising multiple dose study and choice of the appropriate “biomarker”. Such a choice enables one to gain an understanding of what the duration of the clinical effect might be and what dose would be required to see it. Reviews of licensing opportunities make use of Dr. Ford’s knowledge of medicinal chemistry. He can often immediately grasp how the new compound fits into the “prior art”. His knowledge of clinical methodology permits him to provide a clinical plan of how to demonstrate its clinical profile. You will also be provided with a fair and balanced appraisal of its therapeutic potential.